OpenURL Connection Search

Select item for more details and to access through your institution.

Convalescent human IgG, but not IgM, from COVID-19 survivors confers dosedependent protection against SARS-CoV-2 replication and disease in hamsters.
Published in:
Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1138629
By:
- King, Hannah A. D.;
- Dussupt, Vincent;
- Mendez-Rivera, Letzibeth;
- Slike, Bonnie M.;
- Tran, Ursula;
- Jackson, Nathan D.;
- Barkei, Erica;
- Zemil, Michelle;
- Tourtellott-Fogt, Emily;
- Kuklis, Caitlin H.;
- Soman, Sandrine;
- Ahmed, Aslaa;
- Porto, Maciel;
- Kitajewski, Christopher;
- Spence, Brittany;
- Benetiene, Dalia;
- Wieczorek, Lindsay;
- Kar, Swagata;
- Gromowski, Gregory;
- Polonis, Victoria R.
Publication type:
Article
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG.
Published in:
Virology Journal, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12985-024-02394-y
By:
- Wieczorek, Lindsay;
- Chang, David;
- Sanders-Buell, Eric;
- Zemil, Michelle;
- Martinez, Elizabeth;
- Schoen, Jesse;
- Chenine, Agnes-Laurence;
- Molnar, Sebastian;
- Barrows, Brittani;
- Poltavee, Kultida;
- Charurat, Man E.;
- Abimiku, Alash'le;
- Blattner, William;
- Iroezindu, Michael;
- Kokogho, Afoke;
- Michael, Nelson L.;
- Crowell, Trevor A.;
- Ake, Julie A.;
- Tovanabutra, Sodsai;
- Polonis, Victoria R.
Publication type:
Article
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.
Published in:
Retrovirology, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1742-4690-11-8
By:
- Sholukh, Anton M.;
- Byrareddy, Siddappa N.;
- Shanmuganathan, Vivekanandan;
- Hemashettar, Girish;
- Lakhashe, Samir K.;
- Rasmussen, Robert A.;
- Watkins, Jennifer D.;
- Vyas, Hemant K.;
- Thorat, Swati;
- Brandstoetter, Tania;
- Mukhtar, Muhammad M.;
- Yoon, John K.;
- Novembre, Francis J.;
- Villinger, Francois;
- Landucci, Gary;
- Forthal, Donald N.;
- Ratcliffe, Sarah;
- Tuero, Iskra;
- Robert-Guroff, Marjorie;
- Polonis, Victoria R.
Publication type:
Article
High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging.
Published in:
BMC Genomics, 2014, v. 15, n. 1, p. 864, doi. 10.1186/1471-2164-15-864
By:
- Ehrenberg, Philip K.;
- Geretz, Aviva;
- Baldwin, Karen M.;
- Apps, Richard;
- Polonis, Victoria R.;
- Robb, Merlin L.;
- Kim, Jerome H.;
- Michael, Nelson L.;
- Thomas, Rasmi
Publication type:
Article
Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.
Published in:
Virology Journal, 2009, v. 6, p. 1, doi. 10.1186/1743-422X-6-57
By:
- Blanco, Jorge C. G.;
- Pletneva, Lioubov M.;
- Wieczorek, Lindsay;
- Khetawat, Dimple;
- Stantchev, Tzanko S.;
- Broder, Christopher C.;
- Polonis, Victoria R.;
- Prince, Gregory A.
Publication type:
Article
Extracellular vesicle isolation methods identify distinct HIV‐1 particles released from chronically infected T‐cells.
Published in:
Journal of Extracellular Vesicles, 2024, v. 13, n. 7, p. 1, doi. 10.1002/jev2.12476
By:
- Molnar, Sebastian M.;
- Kim, Yuriy;
- Wieczorek, Lindsay;
- Williams, Anastasia;
- Patil, Kajal Ashok;
- Khatkar, Pooja;
- Santos, Mark F.;
- Mensah, Gifty;
- Lorico, Aurelio;
- Polonis, Victoria R.;
- Kashanchi, Fatah
Publication type:
Article
In Vitro Susceptibility of Thai Seronegative Donor CD8+ T Lymphocytes to Human Immunodeficiency Virus-1 (HIV-1) Infection.
Published in:
Asian Pacific Journal of Allergy & Immunology, 2004, v. 22, n. 1, p. 39
By:
- Haponsaph, Ronnarit;
- Darden, Janice M.;
- Chantakulkij, Somsak;
- Sannoi, Nongluck;
- de Souza, Mark S.;
- Brown, Arthur E.;
- Birx, Deborah L.;
- Polonis, Victoria R.;
- Pattanapanyasat, Kovit
Publication type:
Article
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.
Published in:
Journal of Infectious Diseases, 2012, v. 206, n. 3, p. 431, doi. 10.1093/infdis/jis367
By:
- Montefiori, David C.;
- Karnasuta, Chitraporn;
- Huang, Ying;
- Ahmed, Hasan;
- Gilbert, Peter;
- de Souza, Mark S.;
- McLinden, Robert;
- Tovanabutra, Sodsai;
- Laurence-Chenine, Agnes;
- Sanders-Buell, Eric;
- Moody, M. Anthony;
- Bonsignori, Mattia;
- Ochsenbauer, Christina;
- Kappes, John;
- Tang, Haili;
- Greene, Kelli;
- Gao, Hongmei;
- LaBranche, Celia C.;
- Andrews, Charla;
- Polonis, Victoria R.
Publication type:
Article
A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity.
Published in:
PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0231679
By:
- González-Feliciano, José A.;
- Akamine, Pearl;
- Capó-Vélez, Coral M.;
- Delgado-Vélez, Manuel;
- Dussupt, Vincent;
- Krebs, Shelly J.;
- Wojna, Valerie;
- Polonis, Victoria R.;
- Baerga-Ortiz, Abel;
- Lasalde-Dominicci, José A.
Publication type:
Article
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.901217
By:
- Wieczorek, Lindsay;
- Zemil, Michelle;
- Merbah, Mélanie;
- Dussupt, Vincent;
- Kavusak, Erin;
- Molnar, Sebastian;
- Heller, Jonah;
- Beckman, Bradley;
- Wollen-Roberts, Suzanne;
- Peachman, Kristina K.;
- Darden, Janice M.;
- Krebs, Shelly;
- Rolland, Morgane;
- Peel, Sheila A.;
- Polonis, Victoria R.
Publication type:
Article
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
Published in:
2016
By:
- O'Connell, Robert J.;
- Excler, Jean-Louis;
- Polonis, Victoria R.;
- Ratto-Kim, Silvia;
- Cox, Josephine;
- Jagodzinski, Linda L.;
- Liu, Michelle;
- Wieczorek, Lindsay;
- McNeil, John G.;
- El-Habib, Raphaelle;
- Michael, Nelson L.;
- Gilliam, Bruce L.;
- Paris, Robert;
- VanCott, Thomas C.;
- Tomaras, Georgia D.;
- Birx, Deborah L.;
- Robb, Merlin L.;
- Kim, Jerome H.
Publication type:
journal article
Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults.
Published in:
PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0118486
By:
- Joachim, Agricola;
- Nilsson, Charlotta;
- Aboud, Said;
- Bakari, Muhammad;
- Lyamuya, Eligius F.;
- Robb, Merlin L.;
- Marovich, Mary A.;
- Earl, Patricia;
- Moss, Bernard;
- Ochsenbauer, Christina;
- Wahren, Britta;
- Mhalu, Fred;
- Sandström, Eric;
- Biberfeld, Gunnel;
- Ferrari, Guido;
- Polonis, Victoria R.
Publication type:
Article
Detection of HIV-1 Neutralizing Antibodies in a Human CD4+/CXCR4+/CCR5+ T-Lymphoblastoid Cell Assay System.
Published in:
PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0077756
By:
- McLinden, Robert J.;
- LaBranche, Celia C.;
- Chenine, Agnès-Laurence;
- Polonis, Victoria R.;
- Eller, Michael A.;
- Wieczorek, Lindsay;
- Ochsenbauer, Christina;
- Kappes, John C.;
- Perfetto, Stephen;
- Montefiori, David C.;
- Michael, Nelson L.;
- Kim, Jerome H.
Publication type:
Article
Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone.
Published in:
PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0076104
By:
- Chenine, Agnès-Laurence;
- Wieczorek, Lindsay;
- Sanders-Buell, Eric;
- Wesberry, Maggie;
- Towle, Teresa;
- Pillis, Devin M.;
- Molnar, Sebastian;
- McLinden, Robert;
- Edmonds, Tara;
- Hirsch, Ivan;
- O’Connell, Robert;
- McCutchan, Francine E.;
- Montefiori, David C.;
- Ochsenbauer, Christina;
- Kappes, John C.;
- Kim, Jerome H.;
- Polonis, Victoria R.;
- Tovanabutra, Sodsai
Publication type:
Article
Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens.
Published in:
PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045840
By:
- Ratto-Kim, Silvia;
- Currier, Jeffrey R.;
- Cox, Josephine H.;
- Excler, Jean-Louis;
- Valencia-Micolta, Anais;
- Thelian, Doris;
- Lo, Vicky;
- Sayeed, Eddy;
- Polonis, Victoria R.;
- Earl, Patricia L.;
- Moss, Bernard;
- Robb, Merlin L.;
- Michael, Nelson L.;
- Kim, Jerome H.;
- Marovich, Mary A.;
- Hasenkrug, Kim J.
Publication type:
Article
Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41.
Published in:
PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044241
By:
- Mei-Yun Zhang;
- Tingting Yuan;
- Jingjing Li;
- Borges, Andrew Rosa;
- Watkins, Jennifer D.;
- Guenaga, Javier;
- Zheng Yang;
- Yanping Wang;
- Wilson, Richard;
- Yuxing Li;
- Polonis, Victoria R.;
- Pincus, Seth H.;
- Ruprecht, Ruth M.;
- Dimitrov, Dimiter S.;
- Shibo Jiang
Publication type:
Article
Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity.
Published in:
PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038943
By:
- Sholukh, Anton M.;
- Mukhtar, Muhammad M.;
- Humbert, Michael;
- Essono, Sosthène S.;
- Watkins, Jennifer D.;
- Vyas, Hemant K.;
- Shanmuganathan, Vivekanandan;
- Hemashettar, Girish;
- Kahn, Maria;
- Shiu-Lok Hu;
- Montefiori, David C.;
- Polonis, Victoria R.;
- Schur, Peter H.;
- Ruprecht, Ruth M.
Publication type:
Article
The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization.
Published in:
PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0029454
By:
- Brown, Bruce K.;
- Wieczorek, Lindsay;
- Kijak, Gustavo;
- Lombardi, Kara;
- Currier, Jeffrey;
- Wesberry, Maggie;
- Kappes, John C.;
- Ngauy, Viseth;
- Marovich, Mary;
- Michael, Nelson;
- Ochsenbauer, Christina;
- Montefiori, David C.;
- Polonis, Victoria R.
Publication type:
Article
A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.
Published in:
PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024254
By:
- Eller, Michael A.;
- Slike, Bonnie M.;
- Cox, Josephine H.;
- Lesho, Emil;
- Zhining Wang;
- Currier, Jeffrey R.;
- Darden, Janice M.;
- Polonis, Victoria R.;
- Vahey, Maryanne T.;
- Peel, Sheila;
- Robb, Merlin L.;
- Michael, Nelson L.;
- Marovich, Mary A.
Publication type:
Article
B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses.
Published in:
PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0022653
By:
- Oballah, Peter;
- Flach, Britta;
- Eller, Leigh A.;
- Eller, Michael A.;
- Ouma, Benson;
- Souza, Mark de;
- Kibuuka, Hannah N.;
- Wabwire-Mangen, Fred;
- Brown, Bruce K.;
- Michael, Nelson L.;
- Robb, Merlin L.;
- Montefiori, David;
- Polonis, Victoria R.
Publication type:
Article
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate.
Published in:
PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013983
By:
- Currier, Jeffrey R.;
- Ngauy, Viseth;
- de Souza, Mark S.;
- Ratto-Kim, Silvia;
- Cox, Josephine H.;
- Polonis, Victoria R.;
- Earl, Patricia;
- Moss, Bernard;
- Peel, Sheila;
- Slike, Bonnie;
- Sriplienchan, Somchai;
- Thongcharoen, Prasert;
- Paris, Robert M.;
- Robb, Merlin L.;
- Kim, Jerome;
- Michael, Nelson L.;
- Marovich, Mary A.
Publication type:
Article
Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults.
Published in:
PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013849
By:
- Brown, Bruce K.;
- Cox, Josephine;
- Gillis, Anita;
- VanCott, Thomas C.;
- Marovich, Mary;
- Milazzo, Mark;
- Antonille, Tanya Santelli;
- Wieczorek, Lindsay;
- McKee Jr., Kelly T.;
- Metcalfe, Karen;
- Mallory, Raburn M.;
- Birx, Deborah;
- Polonis, Victoria R.;
- Robb, Merlin L.
Publication type:
Article
Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions.
Published in:
PLoS ONE, 2009, v. 4, n. 12, p. 1, doi. 10.1371/journal.pone.0008297
By:
- Beck, Zoltan;
- Brown, Bruce K.;
- Wieczorek, Lindsay;
- Peachman, Kristina K.;
- Matyas, Gary R.;
- Polonis, Victoria R.;
- Rao, Mangala;
- Alving, Carl R.
Publication type:
Article
HIV-1 infections with multiple founders associate with the development of neutralization breadth.
Published in:
PLoS Pathogens, 2022, v. 18, n. 3, p. 1, doi. 10.1371/journal.ppat.1010369
By:
- Lewitus, Eric;
- Townsley, Samantha M.;
- Li, Yifan;
- Donofrio, Gina C.;
- Dearlove, Bethany L.;
- Bai, Hongjun;
- Sanders-Buell, Eric;
- O'Sullivan, Anne Marie;
- Bose, Meera;
- Kibuuka, Hannah;
- Maganga, Lucas;
- Nitayaphan, Sorachai;
- Sawe, Fredrick K.;
- Eller, Leigh Anne;
- Michael, Nelson L.;
- Polonis, Victoria R.;
- Ake, Julie A.;
- Vasan, Sandhya;
- Robb, Merlin L.;
- Tovanabutra, Sodsai
Publication type:
Article
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1339727
By:
- N'guessan, Kombo F.;
- Machmach, Kawthar;
- Swafford, Isabella;
- Costanzo, Margaret C.;
- Wieczorek, Lindsay;
- Dohoon Kim;
- Akapirat, Siriwat;
- Polonis, Victoria R.;
- Punnee Pitisuttithum;
- Nitayaphan, Sorachai;
- Gurunathan, Sanjay;
- Sinangil, Faruk;
- Suwat Chariyalertsak;
- Ake, Julie A.;
- O'connell, Robert J.;
- Vasan, Sandhya;
- Paquin-Proulx, Dominic
Publication type:
Article
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.
Published in:
2020
By:
- Mitchell, Julie L.;
- Takata, Hiroshi;
- Muir, Roshell;
- Colby, Donn J.;
- Kroon, Eugène;
- Crowell, Trevor A.;
- Sacdalan, Carlo;
- Pinyakorn, Suteeraporn;
- Puttamaswin, Suwanna;
- Benjapornpong, Khunthalee;
- Trichavaroj, Rapee;
- Tressler, Randall L.;
- Fox, Lawrence;
- Polonis, Victoria R.;
- Bolton, Diane L.;
- Maldarelli, Frank;
- Lewin, Sharon R.;
- Haddad, Elias K.;
- Phanuphak, Praphan;
- Robb, Merlin L.
Publication type:
journal article
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
Published in:
PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155702
By:
- Joachim, Agricola;
- Bauer, Asli;
- Joseph, Sarah;
- Geldmacher, Christof;
- Munseri, Patricia J.;
- Aboud, Said;
- Missanga, Marco;
- Mann, Philipp;
- Wahren, Britta;
- Ferrari, Guido;
- Polonis, Victoria R.;
- Robb, Merlin L.;
- Weber, Jonathan;
- Tatoud, Roger;
- Maboko, Leonard;
- Hoelscher, Michael;
- Lyamuya, Eligius F.;
- Biberfeld, Gunnel;
- Sandström, Eric;
- Kroidl, Arne
Publication type:
Article

Found: 27

Convalescent human IgG, but not IgM, from COVID-19 survivors confers dosedependent protection against SARS-CoV-2 replication and disease in hamsters.

Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG.

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.

High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging.

Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.

Extracellular vesicle isolation methods identify distinct HIV‐1 particles released from chronically infected T‐cells.

In Vitro Susceptibility of Thai Seronegative Donor CD8+ T Lymphocytes to Human Immunodeficiency Virus-1 (HIV-1) Infection.

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.

A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity.

Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.

Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.

Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults.

Detection of HIV-1 Neutralizing Antibodies in a Human CD4<sup>+</sup>/CXCR4<sup>+</sup>/CCR5<sup>+</sup> T-Lymphoblastoid Cell Assay System.

Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone.

Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens.

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41.

Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity.

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization.

A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.

B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses.

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate.

Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults.

Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions.

HIV-1 infections with multiple founders associate with the development of neutralization breadth.

Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.

Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.